We are excited to announce that the Phenomics Australia node, the Australian Drosophila Transgenic Facility (ADTF), at the Peter MacCallum Cancer Centre, has officially completed its 100th transgenic line!
This milestone reflects the dedication of the team and the value of strong collaborations within the research community. Each line expands the resources available to scientists worldwide, supporting discoveries in genetics, development, and disease modelling. We remain dedicated to expanding this resource and ensuring continued excellence in service to the scientific community. We look forward to the next 100 lines!
The ADTF is co-led by Phenomics Australia Scientific Leaders Prof Kieran Harvey and A/Prof Louise Cheng, an it offers specialised microinjection services for generating transgenic strains of the vinegar fly Drosophila melanogaster.
The mission of the ADTF is to enhance research capabilities for Australian scientists by providing a more cost-effective and streamlined approach to the generation of transgenic Drosophila strains.
From the inception of your project to the delivery of transgenic Drosophila strains, the ADTF facility is here to support your research endeavours.
The ADTF boasts cutting-edge microinjection equipment, ensuring the consistent and efficient production of a diverse array of transgenic Drosophila strains. This state-of-the-art facility offers Australian research centers significant advantages, capitalizing on economies of scale and elevating the overall productivity of their researchers.
ADTF actively fosters collaboration among local researchers, augmenting their appeal to international counterparts. By substantially reducing entry costs and technical barriers associated with Drosophila research, it facilitates a seamless transition for investigators currently immersed in other experimental systems. Moreover, the facility contributes to the expansion of Australia’s research skill set, creating valuable employment and training opportunities in the process.
With an established track record and reputation for excellence, Phenomics Australia In Vivo Genome Engineering and Disease Modelling team uses techniques such as CRISPR-mediated mutagenesis, classical gene targeting, and transgenesis to create optimal tools for your research delivering a comprehensive service in genome modification. To meet the high demand for this platform, Phenomics Australia offers genome editing services through five nodes across Australia, operating at Monash, ANU, WEHI, SAHMRI and PeterMac.
